IL48766A - Process for obtaining intravenous-compatible gamma globulin - Google Patents

Process for obtaining intravenous-compatible gamma globulin

Info

Publication number
IL48766A
IL48766A IL48766A IL4876675A IL48766A IL 48766 A IL48766 A IL 48766A IL 48766 A IL48766 A IL 48766A IL 4876675 A IL4876675 A IL 4876675A IL 48766 A IL48766 A IL 48766A
Authority
IL
Israel
Prior art keywords
gamma globulin
obtaining intravenous
compatible gamma
compatible
intravenous
Prior art date
Application number
IL48766A
Other versions
IL48766A0 (en
Original Assignee
Plasmesco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco Ag filed Critical Plasmesco Ag
Publication of IL48766A0 publication Critical patent/IL48766A0/en
Priority to IL51368A priority Critical patent/IL51368A/en
Publication of IL48766A publication Critical patent/IL48766A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL48766A 1975-01-02 1975-12-30 Process for obtaining intravenous-compatible gamma globulin IL48766A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL51368A IL51368A (en) 1975-12-30 1977-02-01 Process for obtaining intravenous-compatible gamma globulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (en) 1975-01-02 1975-01-02 Process for the production of intravenously tolerated gamma globulins

Publications (2)

Publication Number Publication Date
IL48766A0 IL48766A0 (en) 1976-02-29
IL48766A true IL48766A (en) 1979-11-30

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48766A IL48766A (en) 1975-01-02 1975-12-30 Process for obtaining intravenous-compatible gamma globulin

Country Status (20)

Country Link
JP (1) JPS5512001B2 (en)
AT (1) AT344883B (en)
AU (1) AU505416B2 (en)
BE (1) BE837211A (en)
CA (1) CA1058075A (en)
DD (1) DD121875A5 (en)
DE (1) DE2500076C3 (en)
DK (1) DK144679C (en)
EG (1) EG11987A (en)
ES (1) ES443982A1 (en)
FR (1) FR2296429A1 (en)
GB (1) GB1495159A (en)
IE (1) IE43449B1 (en)
IL (1) IL48766A (en)
IN (1) IN143525B (en)
NL (1) NL179824C (en)
PL (1) PL99599B1 (en)
SE (1) SE437470B (en)
SU (1) SU576898A3 (en)
ZA (1) ZA758050B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (en) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Method of Obtaining IV Compatible Gamma Globulins
JPS6016406B2 (en) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル Method for producing intravenously administrable gamma globulin and gamma globulin prepared thereby
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (en) * 1977-07-19 1983-05-06 株式会社ミドリ十字 Intravenous gamma globulin preparations
AT359641B (en) * 1978-09-19 1980-11-25 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISTRABLE ANTIBODY-CONTAINING IMMUNOGLOBULIN PREPARATE
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (en) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (en) * 1983-05-02 1984-11-03 Pharmacia Ind PROCEDURE FOR PURIFICATION OF BIOLOGICALLY ACTIVE SUBSTANCES
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (en) * 1999-02-21 2000-09-14 Bernd Horst Meier Means for controlling the diffusion of injection solutions
DE10040707A1 (en) * 2000-08-17 2002-03-14 Braun Melsungen Ag Injectable aqueous medicament, containing colloid, e.g. hydroxyethyl starch, to modulate mobility, diffusion, pharmacokinetic and electrophoretic properties of active agent and improve effectiveness
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
PL1976877T5 (en) 2005-11-30 2017-09-29 Abbvie Inc Monoclonal antibodies against amyloid beta protein and uses thereof
CN117903302A (en) 2005-11-30 2024-04-19 Abbvie 公司 Anti-aβ globulomer antibodies, related products thereof, methods of producing said antibodies, uses of said antibodies, and methods of use
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (en) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (en) * 1971-07-16 1973-02-08 South African Inventions METHOD OF MANUFACTURING A PURIFIED GAMMA GLOBULIN
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (en) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
DK584375A (en) 1976-07-03
FR2296429B1 (en) 1978-12-01
IE43449B1 (en) 1981-02-25
SE437470B (en) 1985-03-04
AT344883B (en) 1978-08-10
DD121875A5 (en) 1976-09-05
NL179824C (en) 1986-11-17
NL7514627A (en) 1976-07-06
SU576898A3 (en) 1977-10-15
IL48766A0 (en) 1976-02-29
AU505416B2 (en) 1979-11-22
IN143525B (en) 1977-12-17
NL179824B (en) 1986-06-16
ATA981675A (en) 1977-12-15
ES443982A1 (en) 1977-07-16
DK144679C (en) 1982-10-11
GB1495159A (en) 1977-12-14
DE2500076C3 (en) 1982-11-18
SE7514388L (en) 1976-07-03
JPS5191321A (en) 1976-08-10
AU8792175A (en) 1977-07-14
PL99599B1 (en) 1978-07-31
FR2296429A1 (en) 1976-07-30
BE837211A (en) 1976-06-30
CA1058075A (en) 1979-07-10
DE2500076A1 (en) 1976-07-08
IE43449L (en) 1976-07-02
ZA758050B (en) 1976-12-29
DE2500076B2 (en) 1979-02-22
EG11987A (en) 1981-12-31
JPS5512001B2 (en) 1980-03-29
DK144679B (en) 1982-05-10

Similar Documents

Publication Publication Date Title
YU262076A (en) Process for obtaining 2-phenyl-3-aroylbenzothiophene
JPS527943A (en) Process for preparing same
IL48766A (en) Process for obtaining intravenous-compatible gamma globulin
YU140576A (en) Process for obtaining nifamycin compounds
YU39077A (en) Process for obtaining sulfonyl-benzimidazole compounds
YU237276A (en) Process for obtaining 2-amino-4-pyrimidone derivatives
YU144282A (en) Process for obtaining symmetric bis-carbamoyl-sulfide compounds
YU100676A (en) Process for obtaining piperazinylpyrazine
YU147976A (en) Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin
YU40631B (en) Process for obtaining substituted thiolacarbamates
YU233676A (en) Process for obtaining new n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1554153A (en) Process for making 2-amino-2-alkylthionitroethylenes
YU121176A (en) Process for obtaining rifamcin compounds
YU196776A (en) Process for obtaining phosphor-dichlorido-thiolate
GB1542488A (en) Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile
YU11476A (en) Process for obtaining 6-alkoxy-alpha-carboxy-penicillin
YU262276A (en) Process for obtaining aroyl-phenyl naphthalines
HU172553B (en) Process for producing -3-acyloxymethyl-cepheme- and -3-thiomethyl-cepheme- derivatives
YU40278B (en) Process for obtaining n-alkenyl-2-amino-pyrrolidine
YU39355B (en) Process for obtaining gamma-pyrones
YU109376A (en) Process for obtaining oxazole-carbamide
IL51368A (en) Process for obtaining intravenous-compatible gamma globulin
EG12462A (en) Process for preparing imidazolobenzodiazepines
YU26776A (en) Process for obtaining thieno-pyridine derivatives
YU39980B (en) Process for obtaining 4-amino-trans-decahydroquinoline derivatives